Search Results - "Gray, Norman M"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Effect of Detergent on “Promiscuous” Inhibitors by Ryan, Ali J, Gray, Norman M, Lowe, Peter N, Chung, Chun-wa

    Published in Journal of medicinal chemistry (31-07-2003)
    “…The term “promiscuous” inhibitors has been coined for compounds whose inhibition mechanism involves the interaction of aggregates of many compound molecules…”
    Get full text
    Journal Article
  2. 2

    The role of the cylooxygenase pathway in nociception and pain by Bingham, Sharon, Beswick, Paul J., Blum, David E., Gray, Norman M., Chessell, Iain P.

    Published in Seminars in cell & developmental biology (01-10-2006)
    “…Cycloxygenase (COX) pathways have long been targeted for the treatment of inflammatory pain, initially through the use of NSAIDs. With the demonstration of two…”
    Get full text
    Journal Article
  3. 3

    Development of Cell-Based Assays for In Vitro Characterization of Hepatitis C Virus NS3/4A Protease Inhibitors by Chung, Victoria, Carroll, Anthony R, Gray, Norman M, Parry, Nigel R, Thommes, Pia A, Viner, K Claire, D'Souza, Eric A

    Published in Antimicrobial Agents and Chemotherapy (01-04-2005)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  4. 4

    Pyrrolidine-5,5-trans-lactams. 1. Synthesis and Incorporation into Inhibitors of Hepatitis C Virus NS3/4A Protease by Andrews, David M, Carey, Seb J, Chaignot, Helene, Coomber, Barry A, Gray, Norman M, Hind, S. Lucy, Jones, Paul S, Mills, Gail, Robinson, J. Ed, Slater, Martin J

    Published in Organic letters (12-12-2002)
    “…In this, the first of two letters, we outline the use of the pyrrolidine-5,5-trans-lactam template to design small, neutral, mechanism-based inhibitors of…”
    Get full text
    Journal Article
  5. 5

    A series of penicillin-derived C2-symmetric inhibitors of HIV-1 proteinase: synthesis, mode of interaction, and structure-activity relationships by Humber, David C, Bamford, Mark J, Bethell, Richard C, Cammack, Nicholas, Cobley, Kevin, Evans, Derek N, Gray, Norman M, Hann, Michael M, Orr, David C

    Published in Journal of medicinal chemistry (01-10-1993)
    “…The C2-symmetric diester 1 was identified by random screening as a novel inhibitor of HIV-1 proteinase. This led to the preparation of a series of related more…”
    Get full text
    Journal Article
  6. 6

    Large scale expression and purification of recombinant HIV-1 proteinase from Escherichia coli by Singh, O M, Baines, D S, Hall, R M, Gray, N M, Weir, M P

    Published in Journal of biotechnology (01-11-1991)
    “…The availability of target proteins in sufficient quantity is a limiting factor in crystallographic studies and therefore in rational drug design. Even after…”
    Get more information
    Journal Article
  7. 7
  8. 8

    The intracellular phosphorylation of (−)-2′-deoxy-3′-thiacytidine (3TC) and the incorporation of 3TC 5′-monophosphate into DNA by HIV-1 reverse transcriptase and human DNA polymerase γ by Gray, Norman M., Marr, Clara L.P., Penn, Charles R., Cameron, Janet M., Bethell, Richard C.

    Published in Biochemical pharmacology (28-09-1995)
    “…(−)-2′-deoxy-3′-thiacytidine (3TC) † † 3TC is a trademark of Glaxo Group Ltd., Glaxo House, Greenford Road, Greenford, Middlesex UB6 OHE, U.K. has been shown…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Discovery and analysis of a series of C2-symmetric HIV-1 proteinase inhibitors derived from penicillin by Gray, N M, Cameron, J M, Cammack, N, Cobley, K N, Holmes, D S, Humber, D C, Orr, D C, Penn, C R, Potter, R, Madar, S

    Published in Analytical biochemistry (01-01-1994)
    “…In order to identify a suitable peptide substrate for human immunodeficiency virus-1 (HIV-1) proteinase, a range of peptides from various cleavage sites within…”
    Get more information
    Journal Article